English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

FDA prepares decisions on key therapies from REGENXBIO, Merck, Sanofi/Regeneron

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Penn Medicine expands holistic cancer care with Whole Person Care Collaborative

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Penn Medicine study finds rising use of methadone but calls for wider access

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Regulating immune response could help protect neurons in Parkinson’s disease

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Study finds people feel more empathy for loved ones’ internal bodily pain

+ Pharmaceuticals
Patient Daily | Feb 10, 2026

Bat virome study reveals diversity and links to pig virus origins in Indochina

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones

  • « First
  • «
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily